CAR-Like T Cells Enhance Tumor Response in Gastroesophageal Cancer

Last updated: January 20, 2026 2:25 am

0 Min Read

MedPage Today) — SAN FRANCISCO — The response rate in metastatic gastroesophageal cancer improved by a relative 50% when patients received experimental activated T cells in addition to standard therapy, according to a small phase II study…

Leave a Reply Cancel reply

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

Refresh Screen

Ads Blocker Detected & This Is Prohibited!!!

Refresh Screen

Top Stories

Australian Open: Britain’s Arthur Fery records statement first-round win over Wimbledon quarter-finalist Flavio Cobolli

7 costly reasons Bills were doomed in excruciating playoff loss to Broncos

Drake Powell’s Recent Defensive Stretch is Uncharacteristic of a Rookie

Stay Connected

CAR-Like T Cells Enhance Tumor Response in Gastroesophageal Cancer

Leave a Reply Cancel reply

Related Stories

Regimen Improves PFS in Highly Mutated Metastatic Colorectal Cancer

Multiple Sclerosis Risk May Start Before Birth

Judge finds illegal language in Michigan health department’s proposal to restructure state mental health services

A novel DNA-based therapy achieves significant increase in overall survival in platinum resistant ovarian cancer

How Often Do Physicians Encounter ‘Difficult’ Patients?

Ghanaian celebrities are dealing with mental illness stigma behind closed doors—why speaking up matters

Iowa doesn’t have enough OB-GYNs: The state’s abortion ban might be making it worse

Colorado’s getting $1 billion to ‘transform’ rural health care: Hospitals aren’t thrilled with the state’s plan